A Mitochondria-Targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease Patients

targeting mitochondria 2021 Dr.Paulo J. OliveiraDr. Paulo J. Oliveira from University of Coimbra, Portugal will join the Targeting Mitochondria 2021 congress and will present a talk entitled A Mitochondria-Targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease Patients".

Dr. Oliveira highlighted: "We are developing a lead mitochondria-targeted hydroxycinnamic acid derivative with potential use in different diseases with a mitochondrial dysfunction component.  This talk will focus on our recent study investigating the effects of our novel molecule on skin fibroblasts from sporadic Parkinson's Disease (PD) patients. Our data shows a positive impact of this molecule on mitochondrial function and redox signaling, paving the way to further in vivo studies to validate this molecule in a PD model".

 

Targeting Mitochondria 2021 Congress
October 27-29, 2021
Berlin, Germany & Virtual Congress
www.targeting-mitochondria.com

 

Welcome to Targeting Mitochondria 2021

On behalf of the Scientific Committee of the World Mitochondria Society (WMS) we are excited to announce that the 12th Conference on Targeting Mitochondria for October 27-29, 2021 will be held as an Interactive Online Congress with live slots where many discussions and networking will unite all speakers, presenters and attendees.

On this occasion I would like to state frankly that the success of our virtual congress exceeded my expectations. From the numerous feedbacks we have received I can conclude that COVID-19 was unable to diminish our enthusiasm for the cell organelle we all revere so much. Even more, the special online format we chose seemed to have provided some unexpected benefits. For example, there was no Session Chair who had to enforce any schedule, which allowed for more extensive discussion sections as appreciated by many of us. Further, the availability of all conference contributions for an extended period of time was certainly also a very valuable feature of our 11th conference. Nevertheless, one of the most important aspects of any scientific meeting was missing, which is the personal interaction with colleagues from around the world, be it in the lecture hall, or during the coffee break or last but not least during our conference dinner. Therefore we all are very much looking forward to the next, the 12th edition of our conference series.

Independent on its format, any conference can only be as good as its speakers and its organizers. Knowing that the Organizing Committee under Prof. Marvin Edeas’ leadership will again excel in setting up the next conference, and knowing that the Scientific Committee will again invite key players in the field of Mitochondrial Medicine I assure anyone who is going to join us in this year's Interactive Online Congress on October 2021 that you won’t be disappointed, excellent interactive platform, again excellent speakers and again an excellent organization!

While we have just started working on the outline of our next conference edition, I believe that the overarching themes of our 12th World Congress on Targeting Mitochondria will not significantly deviate from topics discussed at preceding editions of our conference series. Again, we will focus on three major areas, which are first the role of mitochondrial dysfunction in etiology and pathogenesis of chronic diseases including aging, second how to assess and above all quantify mitochondrial dysfunction in vitro and in vivo and finally, third, how to target and manipulate mitochondrial function in order to develop future mitochondria-based therapies. However, we will also try to further extend the profile and scope of our conference by inviting researchers who have never participated in our meeting before, established and new investigators alike.

Basic scientists working at the bench in the laboratory, physicians treating patients suffering from mitochondrial disorders as well as representatives of companies working on the commercialization of mitochondria-targeted therapies are all welcome to our conference. We strongly believe that our 12th World Congress on Targeting Mitochondria will be at least as exciting and as successful as our virtual 11th conference. Please feel free to contact us at any time for further information and with questions you might have.

All our warmest regards.

Targeting Mitochondria 2021-Volkmar-Weissig    

Prof. Volkmar Weissig
President of the World Mitochondria Society
Midwestern University, USA

Online Workshop - How to Evaluate Mitochondria Function ?

How-to-Evaluate-Mitochondria-Function v1

The aim of this workshop is to discuss the last advances in mitochondria assessment and evaluation. The workshop will be interactive and will be recorded.
if you wish to have a short talk during the workshop, please contact us.

Workshop-Agenda

Neurodegeneration and Mitochondria

Mitochondria-Speakers-Ming-Guo

Prof. Ming Guo from UCLA David Geffen School of Medicine, USA will join the Targeting Mitochondria 2020 Congress which will be held in Berlin, Germany on October 29-30, 2020 and present her research during the talk entitled "Neurodegeneration and Mitochondria".

Summary of the Talk: Mitochondrial dysfunction has emerged as a common shared mechanism across multiple neurodegenerative disorders. This includes Parkinson’s disease, myopathy/frontotemporal dementia and ALS. The talk will discuss the latest research regarding these areas. 

 Targeting Mitochondria 2020 Congress
October 29-30, 2020 - Virtual Congress
www.mitochondria-site.com

Mitochondria Devices: New Methods to Detect Mitochondria Dysfunction

https://targeting-mitochondria.com/images/2020/speakers/Mitochondria-Speakers-Naig-Gueguen-v3.jpgDr. Naïg Gueguen from  MitoVasc Institute, Angers University Hospital Center, France will give a presentation entitled "Mitochondria Devices: New Methods to Detect Mitochondria Dysfunction" during the Targeting Mitochondria 2020 Congress which will be organized virtually, on October 29-30, 2020.

Summary of the presentation: Alterations in bioenergetics metabolism represent a common clue in the pathogenesis of several diseases, including metabolic disorders, neurodegenerative disease, inflammatory conditions and cancer. Progress toward deciphering the precise role of the mitochondria in disease etiology requires tools and methods that can dissect the complex interplay between multiple enzymes and oxidative pathways that act cooperatively to regenerate ATP and sustain cellular biosynthesis needs. Recent developments in respirometry, coupled to fluorometry/luminescence, allow multiplexing measurements and provide now routine analyses of a variety of processes, including metabolic rewiring, substrate supply pathways, the activities of the different respiratory chain complexes, ATP synthesis or proton leak. In this context, the choice of the relevant experimental model and design are key elements for the identification and quantification of mitochondrial dysfunctions.

Targeting Mitochondria 2020 Congress
October 29-30, 2020 - Virtual Congress
www.targeting-mitochondria.com

The Cell-free respiratory Competent Mitochondria in Blood: Strategic Role and Application

Mitochondria-Speakers-Alain-ThierryProf. Alain Thierry from Montpellier Cancer Research Institute, INSERM, France will join the Targeting Mitochondria 2020 Congress which will be organized virtually and give a major presentation entitled "The Cell-free respiratory Competent Mitochondria in Blood: Strategic Role and Application".

The researchers used previous findings which showed that the plasma of a healthy individual contains up to 50,000 times more mitochondrial DNA than nuclear DNA. They hypothesized that for it to be detectable and quantifiable in the blood in this manner, the mitochondrial DNA had to be protected by a structure of sufficient stability. In order to identify such a structure, plasma samples from around 100 individuals were analyzed.

This analysis revealed the presence in the blood circulation of highly stable structures containing whole mitochondrial genomes. Following examination of their size and density, as well as the integrity of their mitochondrial DNA, these structures observed using electron microscopy (up to 3.7 million per ml of plasma) were revealed to be intact and functional mitochondria.

Read the complete news here: A New Blood Component Revealed

Targeting Mitochondria 2020 Congress
October 29-30, 2020
www.targeting-mitochondria.com

Mitochondrial disease community registry (MDCR): Perspectives from patients and families, lessons learned from the data

Mitochondria-Speakers-Sophia-zilberMrs. Sophia Zilber from Boston, USA will join the Targeting Mitchondria 2020 Congress and will give a presentation entitled "Mitochondrial disease community registry (MDCR): Perspectives from patients and families, lessons learned from the data".

Patient-populated registries are an important component of rare disease communities for many reasons, including their use as a tool for gathering opinions on specific topics. The Mitochondrial Disease Community Registry (MDCR) was launched in 2014 by United Mitochondrial Disease Foundation (UMDF) for this purpose as well as to identify and characterize mitochondrial disease patients from the patient perspective. This talk presents data collected over a four year period and provided by adult mitochondrial disease patients and caregivers of pediatric mitochondrial disease patients. Findings suggest the importance of clinician-patient communication, need for treatment and cure, the impact of the disease on the entire life of a person, and quality of life as top issues as described by patients, while also highlighting that patients are hopeful and optimistic.  Additionally, data quality checks showed that more clear and simple questions and shorter more-targeted surveys are needed in order to get accurate and meaningful data for research.

 

Targeting Mitochondria 2020 Congress
October 29-30, 2020
www.targeting-mitochondria.com

Down Syndrome: Role of hydrogen sulfide overproduction in the pathogenesis of mitochondrial dysfunction

Mitochondria Speakers Csaba SzaboThe Organizing Committee of Targeting Mitochondria 2020 honored to welcome Prof. Csaba Szabo from the Université de Fribourg, Switzerland.

Prof. Szabo will give a talk entitled "Down Syndrome: Role of hydrogen sulfide overproduction in the pathogenesis of mitochondrial dysfunction" during the congress which will be held on October 29-30, 2020 in Berlin, Germany.

Summary of the talk:  Cystathionine-β-synthase (CBS) is one of the key mammalian enzymes that is responsible for the biological production of the gaseous transmitter hydrogen sulfide (H2S). When H2S is overproduced, it can exert detrimental cellular effects, in part due to inhibition of mitochondrial Complex IV activity. An increased expression of CBS and the consequent overproduction of H2S is well documented in individuals with Down syndrome (DS). Two decades ago, it has been proposed that a toxic overproduction of H2S importantly contributes to the metabolic and neurological deficits associated with DS. However, until recently, this hypothesis has not yet been tested experimentally. The present talk will present recent data generated in human dermal fibroblasts showing that DS cells overproduce H2S, which, in turn, suppresses mitochondrial Complex IV activity and impairs mitochondrial oxygen consumption and ATP generation. Therapeutic CBS inhibition lifts the tonic (and reversible) suppression of Complex IV: this results in the improvement of mitochondrial function in DS cells.

 

Targeting Mitochondria 2020 Congress
October 29-30, 2020 - Berlin, Germany
www.mitochondria-site.com

Mitochondrial Dysfunction in Autism is Distinct from Mitochondrial Disease

Mitochondria-Speakers-Richard-E.-Frye-v1The Organizing Committee of Targeting Mitochondria 2020 is honored to announce the participation of Prof. Richard E. Frye from Phoenix Children's Hospital, USA.

During the congress, Prof. Frye will give a strategic talk entitled "Mitochondrial Dysfunction in Autism is Distinct from Mitochondrial Disease".

Summary of the talk: Several lines of evidence suggest that mitochondrial function is not normal in many individuals with Autism Spectrum Disorder. However, the patterns of abnormalities found are unlike those seen in classic mitochondrial disease and include unique changes in electron transport chain activity, fatty acid metabolism and regulation of oxidative stress. This talk presents data that suggest that these unique abnormalities are a product of long-term metaplasticity adaptations resulting from exposure to extrinsic or intrinsic physiological stressors such as environmental exposures, microbiome alterations, nutrient deficiencies and/or inflammatory events.

 

Targeting Mitochondria 2020 Congress
October 29-30, 2020 - Berlin, Germany
www.mitochondria-site.com

Roles for mitochondrial dysfunction in Alzheimer’s disease

Benedict-C.-Albens-Mitochondria-2020-congress

The Scientific Committee of Targeting Mitochondria 2020 Congress invited Prof. Benedict C. Albensi from Max Rady College of Medicine - University of Manitoba, Canada to present his research on "Roles for mitochondrial dysfunction in Alzheimer’s disease" during the Targeting Mitochondria 2020 Congress, which will be held on October 29-30, 2020.

According to Prof. Benedict C. Albensi: Alzheimer’s disease (AD) is thought to be associated with multiple factors, where the greatest risk factor for AD is aging. In addition, much research has focused on amyloid beta and tau pathology as causative factors in AD. However, new data involving brain metabolic activity, proposes that altered mitochondria are a major force behind the development of AD. Understanding mitochondrial dysfunction and targeting mitochondrial bioenergetics could be a novel treatment approach holding great promise for preventing or treating AD.

For more information about Targeting Mitochondria 2020: https://targeting-mitochondria.com

 

FBXL4 Deficiency leads to increased clearance of Mitochondria

Mitochondria-Speaker Nils-Göran LarssonThe Organizing Committee of Targeting Mitochondria 2020 Congress is honored to announce the participation of Prof. Nils-Göran Larsson from Karolinska Institutet, Sweden.
Prof. Larsson will give a talk entitled "FBXL4 Deficiency leads to increased clearance of Mitochondria"
during the congress which will be held on October 29-30, 2020.

Summary of the Talk: Pathogenic mutations inFBXL4 lead to OXPHOS defects and mtDNA depletion associated with encephalopathy, developmental regression, epileptic seizures and other types of neurological deficits. Despite the frequent occurrence and severe consequences of FBXL4 mutations in humans, the function of the FBXL4 protein has remained poorly understood. We generated mice that lack FBXL4 and show that they recapitulate important aspects of the human disease, including mtDNA depletion. Using proteomic approaches, we found a general decrease of mitochondrial proteins accompanied by an increase in lysosomal proteins inFbxl4 knockout mice as well as in fibroblasts derived from patients with loss-of-functionFBXL4mutations. Unexpectedly, expression of nuclear genes encoding mitochondrial proteins and mitochondrial translation remained unaffected in the absence of FBXL4. We present data showing that the molecular phenotype instead is explained by increased autophagic removal of mitochondria, leading to a global decrease of cellular mitochondrial content. Treatment with the lysosomal inhibitor ammonium chloride rescues mitochondrial protein stability inFBXL4knockout human cells, consistent with the hypothesis that increased autophagy flux is an important pathophysiological event. Further studies are needed to explore the therapeutic potential of these findings, in particular, whether inhibition of autophagy may provide a strategy for treatment of affected patients.   

Targeting Mitochondria 2020 Congress
October 29-30, 2020
www.targeting-mitochondria.com

Variety of non-coding RNA imported and encoded in mitochondria

Mitochondria-Speakers-Eric-Barrey-V1

A special session will be dedicated to Non-coding RNAs in Nuclear-Mitochondrial Crosstalk: Applications for RNA Medicine

The objective of this special session is to share the latest advances on the ncRNA diversity, molecular mechanisms and their impact on mitochondrial functions and nuclear-mitochondrial crosstalk.

Dr. Eric Barrey from University Paris-Saclay, INRAE, AgroParisTech, France will chair & introduce the session.

For more information about speakers and presentations, please follow this link.

 

 Targeting Mitochondria 2020 Congress
October 29-30, 2020 - Virtual congress
www.mitochondria-site.com

 

Control of cellular bioenergetics by cytosolic calcium

Mitochondria-Speakers Franck Norbert GellerichProf. Franck Norbert Gellerich from Otto-von-Guericke University, Germany will the 11th World Congress on Targeting Mitochondria 2020 Congress which will be held as Virtual Congress in October 29-30, 2020.

Summary of the abstract: To understand the regulation of cellular energy metabolism, it is necessary to consider spatiotemporal fluxes of OXPHOS key metabolites (adenine nucleotides, creatine, creatine phosphate, oxidizable substrates, oxygen, Ca2+) through mitochondrial membranes and dynamic diffusion barriers. I would like to focus on two shuttles supplying the OXPHOS with ADP and with pyruvate as well as their regulation by cytosolic Ca2+ (Ca2+cyt).

 Targeting Mitochondria 2020 Congress
October 29-30, 2020 - Virtual congress
www.mitochondria-site.com

Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis

Mitochondria-Speakers-Don-MahadDr. Don Mahad from University of Edinburgh, United Kingdom,  will join the Targeting Mitochondria 2020 Congress on October 29-30 which will be organized virtually and give a major presentation entitled "Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis".

Axonal loss is the key pathological substrate of neurological disability in demyelinating disorders, including multiple sclerosis (MS). However, the consequences of demyelination on neuronal and axonal biology are poorly understood. The abundance of mitochondria in demyelinated axons in MS raises the possibility that increased mitochondrial content serves as a compensatory response to demyelination.

Enhancement of ARMD, by targeting mitochondrial biogenesis and mitochondrial transport from the cell body to axon, protects acutely demyelinated axons from degeneration. 

Enhancement of mitochondrial dynamics in complex IV deficient neurons protects the axon upon demyelination. Consequently, increased mobilisation of mitochondria from the neuronal cell body to the axon is a novel neuroprotective strategy for the vulnerable, acutely demyelinated axon. We propose that promoting ARMD is likely to be a crucial preceding step for implementing potential regenerative strategies for demyelinating disorders.

 

Targeting Mitochondria 2020 Congress
October 29-30, 2020
www.targeting-mitochondria.com

Targeting Mitochondria 2020 will organized as VIRTUAL Conference

Dear Colleagues,

After a long and thorough discussion among the scientific and organizing committees, we have decided to organize our 11th Conference of Targeting Mitochondria, on October 29-30, 2020 as an ONLY online meeting.

Targeting Mitochondria 2020 Meeting is not a webinar. All registered attendees will have access to the platform when they wish and at any time.

 

Targeting Mitochondria 2020 Virtual Meeting:
Practical Information


Pre-Recorded Contributions:

Due to restriction and time zone difference, a pre-recorded contribution can be separately viewed online from the date of the conference, October 29, 2020, until November 29th, via the use of access code.


Prior to the Conference:

- All Invited Speakers are being asked to record their 25 minutes talks via the conference platform.

- All Short Oral contributions accepted are being asked to record their 10 minutes talks.

- All Poster contributions accepted are being asked to record their 5 minutes talks and submit the poster in PDF Format.


Conference Platform:

All contributions accepted by the scientific committee will be added to the specific conference platform prior to the conference, as indicated in the session of the program.


How to Access to all Communications (à la Carte):

Upon registration, each pre-recorded contribution can be separately viewed online from the date of the conference, October 29, 2020 until November 29th, via the use of access code. The "à la carte" presentations can be viewed in the comfort of your place.


Awards:

As each year, 3 awards will be given: Best scientific contribution, Best short oral presentation and best poster presentation. The best poster will be selected by the vote of all virtual attendees.

 

Questions, Contact, and Networking:

The conference platform will allow each participant to contact speakers, attendees, and sponsors. If you wish to submit your questions to speakers, you can do it before the meeting.

 

Chairmen and Round Table Discussion:

The Chairmen of each session will record an overview of all talks of their session. You can send also your questions to chairmen.

 

Registration:

We updated the registration fees for this WMS 2020 virtual meeting.

If you wish to cancel your registration, please contact us for reimbursement.

You will receive a refund for the difference in the cost of registration or keep the difference for Targeting Mitochondria 2021 congress.

Please feel free to contact us with any questions you might have.


Best regards,

On behalf of

Prof. Volkmar Weissig

President of the World Mitochondria Society